MELBOURNE, Australia and INDIANAPOLIS, April 7, 2026 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) provides a market update on its commercial and operational performance for the quarter ended March 31, 2026 (Q1 2026).

Q1 2026 Highlights

• Q1 2026 unaudited Group revenue of US$230 million, up 11% quarter-over-quarter.

• FY 2026 revenue guidance of US$950 million to US$970 million is reaffirmed.

• Precision Medicine Q1 2026 unaudited revenue of US$186 million, up 16% quarter-over-quarter. Strong revenue growth in both Illuccix® and Gozellix® segments.

• ProstACT® Global Phase 3 study of TLX591-Tx prostate cancer therapy candidate: Part 1 lead-in met safety and dosimetry objectives, with no new safety signals observed^[1].

• TLX101-Px (brain cancer imaging candidate): New Drug Application (NDA) resubmitted to the United States (U.S.) Food and Drug Administration (FDA)^[2] for Pixclara®^[3]. Marketing Authorization Application (MAA) filed in Europe^[4] for Pixlumi®³.

• TLX591-Px^[5]: NDA accepted in China by the National Medical Products Administration (NMPA)^[6].

Q1 2026 Revenue (Unaudited)

Executive Commentary

Dr. Christian Behrenbruch, Managing Director and Group CEO, stated, “Growth accelerated across our Precision Medicine business in the first quarter, with U.S. dose volumes increasing 5% quarter-over-quarter. This performance reflects the growing uptake of Gozellix alongside Illuccix, contributing to market share gains underpinned by disciplined sales execution and pricing, and high-quality service delivery despite extreme North American weather conditions, an advantage of the pharmacy distribution model. With our two‑product PSMA^[9] imaging strategy, differentiated clinical positioning and expanding commercial presence globally, we are seeing a solid foundation for continued growth through 2026. Importantly, we are delivering on our strategic priorities to advance our high-value clinical programs, demonstrated by the momentum in our therapeutics pipeline this quarter.”

Therapeutics Business Unit

Telix continues to progress its industry-leading Therapeutics pipeline, which spans multiple product candidates and disease areas. Q1 2026 highlights include:

• TLX591-Tx (lutetium (¹⁷⁷Lu) rosopatamab tetraxetan): Part 1 of ProstACT Global, the Phase 3 trial of its lead prostate cancer therapy candidate, achieved its study objectives, demonstrating an acceptable safety and tolerability profile with no new safety signals observed¹. No adverse drug-drug interactions were observed in TLX591-Tx combinations, demonstrating the feasibility of integrating TLX591-Tx with current standard of care therapies for mCRPC^[10], including ARPIs^[11] (enzalutamide or abiraterone) and docetaxel. Telix has commenced engagement with the FDA to present data from Part 1 and ascertain eligibility for U.S. patients to participate in Part 2 (randomized treatment expansion). Part 2 is open for enrollment in Australia, New Zealand and Canada, with site activation underway in preparation to open enrollment in China, Singapore, South Korea, Türkiye, the United Kingdom and Japan, where regulatory approvals have already been granted.

• TLX250-Tx (lutetium (¹⁷⁷Lu) girentuximab tetraxetan): Telix has opened its first clinical site and is recruiting patients for Part 1 of LUTEON^[12], a pivotal trial of TLX250-Tx as a monotherapy in advanced ccRCC^[13]. Trial recruitment will initially focus ex-U.S.

• TLX101-Tx (¹³¹I-iodofalan): Telix has enrolled the first patient in IPAX-BrIGHT, an international, multi-center pivotal trial of TLX101-Tx in patients with recurrent glioblastoma^[14]. The trial is now open for enrollment in Australia, Austria and the Netherlands and has received regulatory approval to commence in Belgium.

• TLX090-Tx (¹⁵³Sm-DOTMP): Telix continues to dose patients in SOLACE^[15], a Phase 1 study of a drug candidate for treating pain in patients with osteoblastic bone metastases from prostate and breast cancers. The study was expanded this quarter to include additional U.S. sites to accelerate recruitment. 

• TLX597-Tx (¹⁷⁷Lu-DOTA-HYNIC-panPSMA): TLX597-Tx is a “next generation” PSMA-targeting prostate cancer therapy candidate being developed to facilitate patient access in select geographies, where routine clinical availability to approved therapies is limited or not available. Early clinical data suggests a favorable asset biodistribution with limited uptake in healthy organs of concern (e.g., salivary glands, kidneys) relative to available ¹⁷⁷Lu-PSMA therapies. Interim data from OPTIMAL-PSMA^[16], an investigator-led, randomized, dose intensification study of TLX597-Tx in mCRPC, will be presented at the International Prostate Cancer Symposium in April 2026. 

Precision Medicine Business Unit

PSMA imaging portfolio:

• Telix continues to expand its commercial footprint with Illuccix now launched in 21 countries globally, which includes 16 countries in Europe. This growing international presence enhances access to PSMA-PET/CT imaging^[17] while establishing a scalable commercial and operational platform to support future product launches, including follow-on therapeutic products.

• Telix’s broad proposed label for TLX591-Px (Illuccix) is under review by the NMPA Centre for Drug Evaluation as part of the NDA submission^[18].

TLX101-Px, (Floretyrosine F 18 or ¹⁸F-FET):

• Telix has resubmitted its NDA in the U.S. with the additional clinical data and analysis as agreed with the FDA.

• Telix has submitted a MAA in Europe covering commercially significant markets, seeking to expand patient access to advanced brain imaging.

Zircaix®³ (TLX250-Px, ⁸⁹Zr-DFO-girentuximab):

• Based on two successful Type A meetings with the FDA, Telix believes it has aligned on key outstanding issues for the Biologics License Application (BLA) resubmission, including demonstration of drug product comparability between clinical trial material and scale-up commercial production. The Company is now completing the agreed deliverables and documentation required, targeting a H1 2026 submission.

Corporate Updates

Telix has announced the appointment of David Gill as Non-Executive Director (NED), effective May 11, 2026, as part of its Board renewal process^[19]. Mr. Gill is expected to be appointed as Chair in due course, succeeding Dr. Mark Nelson who will remain on the Board as NED. The Board believes Mr. Gill’s appointment will enhance the Board’s capability, with extensive experience in U.S. public company governance, financial oversight and senior leadership across commercial and clinical-stage biopharmaceutical companies.

FY 2026 guidance

• Telix reaffirms FY 2026 revenue guidance of US$950 million to US$970 million^[20].

• Guidance reflects revenue from product sales in jurisdictions with a marketing authorization, and a full year of revenue contribution from RLS.

• Telix reaffirms research and development (R&D) expenditure guidance of US$200 million to US$240 million, subject to achieving ongoing global commercial milestones.

About Telix Pharmaceuticals Limited

Telix is a global biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals with the goal of addressing significant unmet medical need in oncology and rare diseases. Telix is headquartered in Melbourne (Australia) with international operations in the United States, United Kingdom, Brazil, Canada, Europe (Belgium and Switzerland), and Japan. Telix is listed on the Australian Securities Exchange (ASX: TLX) and the Nasdaq Global Select Market (NASDAQ: TLX).

Illuccix (kit for the preparation of gallium-68 (⁶⁸Ga) gozetotide injection) has been approved by the FDA^[21], and in multiple markets globally. Gozellix (kit for the preparation of gallium-68 (⁶⁸Ga) gozetotide injection) has been approved by the FDA^[22]. No other Telix product mentioned in this announcement has received a marketing authorization in any jurisdiction.

Visit www.telixpharma.com for further information about Telix, including details of the latest share price, ASX and U.S. Securities and Exchange Commission (SEC) filings, investor and analyst presentations, news releases, event details and other publications that may be of interest. You can also follow Telix on LinkedIn, X and Facebook.

This announcement has been authorized for release by the Telix Pharmaceuticals Limited Disclosure Committee on behalf of the Board.

Guidance Disclaimer

The stated revenue guidance is based on expected global and domestic economic conditions and is subject to known and unknown risks, uncertainties and other factors that may cause our actual results to differ materially. As such, investors are cautioned not to place undue reliance on this guidance and in particular Telix cannot guarantee a particular result. In compiling financial forecasts, a number of key variables that may have a significant impact on guidance have been identified and are listed below.

Key variables that could cause actual results to differ materially include: the success and timing of research and development activities; decisions by regulatory authorities regarding approval of our products as well as their decisions regarding label claims; competitive developments affecting our products; the ability to successfully market new and existing products; difficulties or delays in manufacturing; trade buying patterns and fluctuations in interest and currency exchange rates; legislation, regulation, or policy that affects product production, distribution, pricing, reimbursement, access or tax; acquisitions and divestitures; research collaborations; litigation or government investigations; and Telix’s ability to protect its patents and other intellectual property. See the Legal Notices section below for additional information, risks and assumptions.

Legal Notices

Cautionary Statement Regarding Forward-Looking Statements. 

You should read this announcement together with our risk factors, as disclosed in our most recently filed reports with the Australian Securities Exchange (ASX), U.S. Securities and Exchange Commission (SEC), including our Annual Report on Form 20-F filed with the SEC, or on our website.

The information contained in this announcement is not intended to be an offer for subscription, invitation or recommendation with respect to securities of Telix Pharmaceuticals Limited (Telix) in any jurisdiction, including the United States. The information and opinions contained in this announcement are subject to change without notification. To the maximum extent permitted by law, Telix disclaims any obligation or undertaking to update or revise any information or opinions contained in this announcement, including any forward-looking statements (as referred to below), whether as a result of new information, future developments, a change in expectations or assumptions, or otherwise. No representation or warranty, express or implied, is made in relation to the accuracy or completeness of the information contained or opinions expressed in the course of this announcement.

This announcement may contain forward-looking statements, including within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, that relate to anticipated future events, financial performance, plans, strategies or business developments. Forward-looking statements can generally be identified by the use of words such as “may”, “expect”, “intend”, “plan”, “estimate”, “anticipate”, “believe”, “outlook”, “forecast” and “guidance”, or the negative of these words or other similar terms or expressions. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Forward-looking statements are based on Telix’s good-faith assumptions as to the financial, market, regulatory and other risks and considerations that exist and affect Telix’s business and operations in the future and there can be no assurance that any of the assumptions will prove to be correct. In the context of Telix’s business, forward-looking statements may include, but are not limited to, statements about: the initiation, timing, progress, completion and results of Telix’s preclinical and clinical trials, and Telix’s research and development programs; Telix’s ability to advance product candidates into, enroll and successfully complete, clinical studies, including multi-national clinical trials; the timing or likelihood of regulatory filings and approvals for Telix’s product candidates, including TLX101-Px and TLX250-Px, manufacturing activities and product marketing activities; Telix’s sales, marketing and distribution and manufacturing capabilities and strategies; the commercialization of Telix’s product candidates, if or when they have been approved; Telix’s ability to obtain an adequate supply of raw materials at reasonable costs for its products and product candidates; estimates of Telix’s expenses, future revenues and capital requirements; Telix’s financial performance; developments relating to Telix’s competitors and industry; the anticipated impact of U.S. and foreign tariffs and other macroeconomic conditions on Telix’s business, including as a result of war or other geopolitical conflicts; and the pricing and reimbursement of Telix’s product candidates, if and after they have been approved. Telix’s actual results, performance or achievements may be materially different from those which may be expressed or implied by such statements, and the differences may be adverse. Accordingly, you should not place undue reliance on these forward-looking statements.

Trademarks and Trade Names. All trademarks and trade names referenced in this press release are the property of Telix Pharmaceuticals Limited (Telix) or, where applicable, the property of their respective owners. For convenience, trademarks and trade names may appear without the ® or ™ symbols. Such omissions are not intended to indicate any waiver of rights by Telix or the respective owners. Trademark registration status may vary from country to country. Telix does not intend the use or display of any third-party trademarks or trade names to imply any affiliation with, endorsement by, or sponsorship from those third parties.

©2026 Telix Pharmaceuticals Limited. All rights reserved.

SYDNEY, April 7, 2026 /PRNewswire/ — RETOPIA SALON, an entertainment company founded by key former executives from HYBE who played a pivotal role in BTS’s global success, is launching a search for the next generation of K-pop talent in Australia.

The company will host the “2026 RETOPIA SALON GLOBAL AUDITION: AUSTRALIA” across Sydney, Melbourne, and Brisbane this May. The audition schedule is as follows:

• May 13 – Sydney, IX Dance Studio
• May 17 – Melbourne, X-Dance Station and O2 KPOP ACADEMY
• May 19 – Brisbane, XPACE STUDIO BRISBANE
• May 20 – Gold Coast, YJ DANCE SCHOOL GOLD COAST

Applicants born between 2008 and 2014 are eligible to participate regardless of gender or nationality. Participants may choose one category to audition in: vocal, rap, dance, or acting.

“We aim not only to select the final members of our first boy group set to debut in 2027, but also to discover hidden talent for future girl group projects,” said RETOPIA SALON. “We look forward to passionate applicants from around the world who dream of becoming global stars.”

Beyond Australia, RETOPIA SALON plans to conduct a large-scale global audition tour across 18 cities worldwide, including Japan (Sendai, Okinawa, Osaka, Kyoto, Tokyo, Chiba, Fukuoka), Indonesia (Jakarta, Bandung), Thailand (Bangkok, Chiang Mai), the United States (Los Angeles, Orange County, Honolulu), and Canada (Toronto).

Further details about the auditions can be found via RETOPIA SALON’s official social media channels and local partner academies:
https://www.instagram.com/retopia.salon/

About RETOPIA SALON

RETOPIA SALON is an entertainment company founded by industry leaders who were instrumental in driving BTS’s global success during their time at HYBE. The founding team includes CEO Bang Woo Jung (former Creative Studio Leader at HYBE Media Studio), CCO Kim Serene (former VP of HYBE LABELS JAPAN), and COO Park Jun Soo (former SP at HYBE Original Content Studio).

Leveraging their extensive industry experience and expertise, the company is engaged in artist management and content production. RETOPIA SALON is currently preparing to debut its first boy group in 2027.

The team has also contributed to a range of high-profile content projects, including BTS Jin’s YouTube variety show Run Jin and the Disney+ original series Are You Sure?! Season 2 featuring Jimin and Jung Kook, drawing significant attention both within and beyond the industry.

Enhances scalable EPMS capabilities, strengthens hyperscale data center offering, and establishes a strategic foundation for Latin American growth.

• The deal expands AZZO’s ability to deliver standardized EPMS across multi-site, mission-critical portfolios
• Qubits Energy brings proven expertise in deploying energy systems for hyperscale data centers and colocation providers
• Integration with AZZO’s EnergyX® platform creates a unified solution for monitoring, control, and energy optimization
• The acquisition enhances automation capabilities through AI-enabled engineering and deployment
• AZZO gains an immediate operational footprint in Latin America via Qubits Energy’s Colombia presence
• The combined business is positioned to support rapid global growth in data center and digital infrastructure markets
• The transaction strengthens AZZO’s position in mission-critical infrastructure, where reliability and scalability are essential

NASHVILLE, Tenn., April 6, 2026 /PRNewswire/ — AZZO, a leading energy technology and services company, today announced the acquisition of Qubits Energy, a specialist in Electrical Power Management Systems (EPMS), advanced automation, and energy management solutions for data centers and other mission-critical facilities.

The acquisition expands AZZO’s ability to deliver standardized, high-performance energy management systems across global data center and critical infrastructure portfolios, while establishing a strategic foothold in Latin America.

Qubits Energy, headquartered in Nashville, Tennessee, has built a strong reputation for delivering EPMS across large, distributed environments. Its engineering-led approach enables rapid deployment, consistency across sites, and high operational reliability.

By integrating Qubits Energy’s capabilities into its EnergyX® platform, AZZO will deliver a unified architecture for monitoring, automation, and control across complex energy environments. This integration enhances AZZO’s ability to support customers operating at scale specifically in high-growth sectors such as data centers.

Qubits Energy brings established relationships with hyperscale data center owners and major colocation providers, supporting environments where uptime, scalability, and speed of deployment are critical. These capabilities complement AZZO’s EnergyX® platform and lifecycle services, positioning the combined organization to deliver consistent energy management systems across global portfolios, support rapid expansion of data center infrastructure in North America, and improve operational efficiency and reliability at scale.

The acquisition also provides AZZO with an established operational presence in Colombia, creating a foundation for growth across Latin America, a region experiencing increasing demand for digital infrastructure and energy resilience. This presence enables local engineering and delivery capabilities, supports global customers expanding into LATAM markets, and allows for scalable deployment of EnergyX® solutions across emerging data center hubs.

James DiLiberto, CEO of AZZO, said:

“Data center growth is accelerating globally, driving demand for standardized, scalable energy management solutions. Qubits Energy has demonstrated the ability to deliver these systems across complex, multi-site environments. By combining their expertise with AZZO’s EnergyX® platform and lifecycle services, we can offer a unified solution to support the next generation of mission-critical infrastructure.”

Ivan Ospina, CEO of Qubits Energy, added:

“Joining AZZO enables us to expand our reach and deliver our EPMS and automation capabilities on a global scale. Together, we are well positioned to provide intelligent, standardized energy systems to some of the world’s most demanding data center environments.”

Qubits Energy’s team and solutions will be integrated into AZZO immediately. AZZO plans to accelerate investment in AI-driven automation and mission-critical services within its EnergyX® platform.

About AZZO

AZZO is an energy technology and services company that helps customers manage complex energy ecosystems. With over 20 years of experience, AZZO specializes in microgrids and energy management for critical infrastructure. Its EnergyX® platform provides real-time visibility, control, and analytics to deliver energy resilience, improved economics, and operational flexibility. For more information, please visit www.azzo.com.

About Qubits Energy

Qubits Energy delivers standardized Electrical Power Management Systems (EPMS) for mission-critical facilities, with a focus on multi-site data center environments. Its engineering-led approach and automation capabilities enable consistent, high-performance implementations across global portfolios. For more information, please visit www.qubitsenergy.com.

Enhances scalable EPMS capabilities, strengthens hyperscale data center offering, and establishes a strategic foundation for Latin American growth.

• The deal expands AZZO’s ability to deliver standardized EPMS across multi-site, mission-critical portfolios
• Qubits Energy brings proven expertise in deploying energy systems for hyperscale data centers and colocation providers
• Integration with AZZO’s EnergyX® platform creates a unified solution for monitoring, control, and energy optimization
• The acquisition enhances automation capabilities through AI-enabled engineering and deployment
• AZZO gains an immediate operational footprint in Latin America via Qubits Energy’s Colombia presence
• The combined business is positioned to support rapid global growth in data center and digital infrastructure markets
• The transaction strengthens AZZO’s position in mission-critical infrastructure, where reliability and scalability are essential

NASHVILLE, Tenn., April 6, 2026 /PRNewswire/ — AZZO, a leading energy technology and services company, today announced the acquisition of Qubits Energy, a specialist in Electrical Power Management Systems (EPMS), advanced automation, and energy management solutions for data centers and other mission-critical facilities.

The acquisition expands AZZO’s ability to deliver standardized, high-performance energy management systems across global data center and critical infrastructure portfolios, while establishing a strategic foothold in Latin America.

Qubits Energy, headquartered in Nashville, Tennessee, has built a strong reputation for delivering EPMS across large, distributed environments. Its engineering-led approach enables rapid deployment, consistency across sites, and high operational reliability.

By integrating Qubits Energy’s capabilities into its EnergyX® platform, AZZO will deliver a unified architecture for monitoring, automation, and control across complex energy environments. This integration enhances AZZO’s ability to support customers operating at scale specifically in high-growth sectors such as data centers.

Qubits Energy brings established relationships with hyperscale data center owners and major colocation providers, supporting environments where uptime, scalability, and speed of deployment are critical. These capabilities complement AZZO’s EnergyX® platform and lifecycle services, positioning the combined organization to deliver consistent energy management systems across global portfolios, support rapid expansion of data center infrastructure in North America, and improve operational efficiency and reliability at scale.

The acquisition also provides AZZO with an established operational presence in Colombia, creating a foundation for growth across Latin America, a region experiencing increasing demand for digital infrastructure and energy resilience. This presence enables local engineering and delivery capabilities, supports global customers expanding into LATAM markets, and allows for scalable deployment of EnergyX® solutions across emerging data center hubs.

James DiLiberto, CEO of AZZO, said:

“Data center growth is accelerating globally, driving demand for standardized, scalable energy management solutions. Qubits Energy has demonstrated the ability to deliver these systems across complex, multi-site environments. By combining their expertise with AZZO’s EnergyX® platform and lifecycle services, we can offer a unified solution to support the next generation of mission-critical infrastructure.”

Ivan Ospina, CEO of Qubits Energy, added:

“Joining AZZO enables us to expand our reach and deliver our EPMS and automation capabilities on a global scale. Together, we are well positioned to provide intelligent, standardized energy systems to some of the world’s most demanding data center environments.”

Qubits Energy’s team and solutions will be integrated into AZZO immediately. AZZO plans to accelerate investment in AI-driven automation and mission-critical services within its EnergyX® platform.

About AZZO

AZZO is an energy technology and services company that helps customers manage complex energy ecosystems. With over 20 years of experience, AZZO specializes in microgrids and energy management for critical infrastructure. Its EnergyX® platform provides real-time visibility, control, and analytics to deliver energy resilience, improved economics, and operational flexibility. For more information, please visit www.azzo.com.

About Qubits Energy

Qubits Energy delivers standardized Electrical Power Management Systems (EPMS) for mission-critical facilities, with a focus on multi-site data center environments. Its engineering-led approach and automation capabilities enable consistent, high-performance implementations across global portfolios. For more information, please visit www.qubitsenergy.com.

Latest financing builds on recent capital momentum for structurally important American iron ore project

NASHWAUK, Minn., April 6, 2026 /PRNewswire/ — Mesabi Metallics Company LLC (Mesabi Metallics), backed by Essar Group, today announced that it has secured $150 million of financing from Macquarie Group, supporting the Q3 2026 startup of its world-scale Direct Reduction (DR) grade iron ore mine and pellet plant in Nashwauk, Minnesota.

Mesabi Metallics concentrator building

The financing follows Mesabi’s recently announced $520 million senior secured credit facility with Breakwall Capital, further reinforcing the strong momentum behind the project.

Mesabi has also recently received support from the U.S. Export-Import Bank (EXIM), reflecting the project’s growing strategic importance to U.S. manufacturing, infrastructure, automotive, shipbuilding and defense.

Mesabi Metallics is building a strategically important new American source of DR-grade iron ore at a time when the United States is working to strengthen industrial supply chains and reduce reliance on imported raw materials.

Located on more than 16,000 acres in Northern Minnesota, Mesabi Metallics is completing a $2.5 billion world-scale merchant DR-grade iron ore mine and pellet plant that will supply the next generation electric arc furnaces of American steelmaking- the cleanest and most energy efficient way of making high quality steel.

With more than 800 construction workers currently on site, the project is one of the largest private-sector industrial investments in Minnesota’s history. Essar Group has already invested more than $2 billion of equity into the project.

“This financing from Macquarie marks another major step forward for Mesabi Metallics and builds on the strong momentum we have established with our recently announced financial partnerships,” said Joe Broking, President and CEO of Mesabi Metallics. “Together, these transactions reflect growing confidence in the quality, scale and strategic importance of our project as we build a new American source of DR-grade iron ore to strengthen domestic steel supply chains and reduce dependence on imports.”

“Macquarie has enjoyed a longstanding financing relationship with Essar Group, and we are pleased to extend that relationship to their metals and mining investments in the US,” said Mike Burns, Senior Managing Director in Macquarie Group’s Commodities and Global Markets business. “Mesabi is developing a high-quality and strategically important project for the U.S. steel sector, and we look forward to supporting the company over the long term.”

About Mesabi Metallics Company LLC 

Mesabi Metallics Company LLC, an Essar Group company, is constructing a state-of-the-art mine and Direct Reduction (DR) grade iron ore pellet plant to produce premium DR grade pellets on over 16,000 acres in Nashwauk, Minnesota. Once completed, it will be the first new mine and pellet plant in Minnesota in almost 50 years. Mesabi’s DR grade iron ore pellets will be strategically positioned to meet the demand of the Electric Arc Furnace market, ensuring supply chain security for DR grade iron pellets in the United States and replacing foreign imported pellets. The endeavor is one of the largest private sector investments in Minnesota. Mesabi Metallics has already invested over $2.2 billion into the project.

Capturing new angles like never before, Galaxy S26 Ultra’s broadcast-ready capture transforms how skateboarding is filmed, experienced and delivered in real time

LOS ANGELES, April 6, 2026 /PRNewswire/ — Samsung Electronics Co., Ltd., a global partner of Street League Skateboarding (SLS) today announced that Galaxy S26 Ultra was used to film live Street League Skateboarding (SLS) competition for the first time when it captured the SLS DTLA Takeover on April 4. Galaxy S26 Ultra’s pro-grade camera redefines the role of mobile devices in sports, delivering a fresh visual experience of skateboarding that reflects the intensity of the sport itself.

Samsung Galaxy S26 Ultra POV captures new perspectives at SLS DTLA Takeover on April 4, 2026 (Photo courtesy of Getty Images / Samsung).

Sports broadcasting is evolving, bringing fans closer to the experience by moving cameras closer to the action. Samsung is driving this shift with the Galaxy camera system and its ability to operate at broadcast-level performance through the pairing of connectivity and mobility. Earlier this year, Galaxy flagship device was used to stream Opening Ceremony of the Olympic Winter Games Milano Cortina 2026, where Samsung worked alongside Olympic Broadcasting Services (OBS) to embed Galaxy devices throughout the venue at one of the world’s largest sports stages. The result was a new layer of visual storytelling, capturing dynamic perspectives that complemented traditional broadcast coverage. These capabilities extended to the Galaxy Unpacked 2026, showcasing its ability to deliver professional-grade video capture and transmission.

Now, Samsung is helping lead this transformation within skateboarding competitions by embedding Galaxy S26 Ultra directly into key course features — including rails, ledges and gaps — across the entire SLS 2026 season, fully scaling the Galaxy POV first introduced at the 2026 SLS Sydney stop.

“Mobile innovation is opening new possibilities for how sports are captured and experienced,” said Joshua Cho, Executive Vice President and Head of the Visual Solution Team, Mobile eXperience (MX) Business at Samsung Electronics. “At Milano Cortina we demonstrated how Galaxy technology can complement traditional broadcast systems. With Street League Skateboarding, we’re bringing that same approach directly into the course with our newest, most advanced device camera, and using mobile POV to capture skateboarding from entirely new perspectives.”

Embedded throughout the course, the devices provide skater-level perspectives, offering angles that traditional broadcast systems often cannot capture. This footage feeds directly into the live production workflow, enabling near-instant replay and offering viewers a fresh visual experience that reflects the intensity of the sport itself.

From speed to the precision of every landing, skateboarding is defined by details that are often lost from a distance. With mobile cameras placed directly inside the course, Samsung is reimagining how the sport is experienced, bringing fans closer to each mid-air movement, board flip and landing. These new perspectives offer deeper insight into technique, timing and control, while strengthening the connection between fans, the sport and the athlete.

Featuring Samsung’s most advanced mobile imaging system to date, Galaxy S26 Ultra is designed to perform in fast-moving, unpredictable environments, much like the athletes themselves. It delivers professional-grade camera performance and high-quality footage across a wide range of shooting conditions with enhanced stabilization, intelligent processing and the ability to maintain clarity in low-light or high-speed conditions. This allows it to operate alongside conventional cameras while maintaining clarity, stability and detail within spaces traditional broadcast cameras cannot easily access.

The placement of Galaxy S26 Ultra devices follows the rhythm and flow of each run, revealing the style, speed and precision of each trick from within the course itself. Galaxy features also extend the creative possibilities of production. Features such as Super Steady with horizontal lock stabilization help maintain smooth, level footage even during high-speed motion, while Instant Slow-Mo enables detailed replay of tricks as they happen. Together, these capabilities allow production teams to capture skateboarding with greater clarity, stability and proximity — showcasing the precision, style and technical skill behind every movement.

“Skateboarding is reaching more people than ever before, especially as the sport continues to grow on the global stage,” said Brett Clarke, Chief Revenue Officer at Thrill Sports, the parent company of Street League Skateboarding. “Collaborations like the one we have with Samsung help us evolve how the sport is shared with fans while staying true to the creativity and culture that define skateboarding.”

The debut of Galaxy S26 Ultra POV integration at the SLS DTLA Takeover signals where sports broadcasting is heading next. As the SLS Championship Tour continues, Samsung will continue exploring how mobile technology can evolve into versatile broadcast tools. Looking ahead to major global sporting events and the road to Los Angeles 2028, this shift suggests a future in which the boundary between smartphone camera and broadcast camera continues to disappear, bringing fans closer to the action.

About Samsung Electronics Co., Ltd.
Samsung inspires the world and shapes the future with transformative ideas and technologies. The company is redefining the worlds of TVs, digital signage, smartphones, wearables, tablets, home appliances and network systems, as well as memory, system LSI and foundry. Samsung is also advancing medical imaging technologies, HVAC solutions and robotics, while creating innovative automotive and audio products through Harman. With its SmartThings ecosystem, open collaboration with partners, and integration of AI across its portfolio, Samsung delivers a seamless and intelligent connected experience. For the latest news, please visit the Samsung Newsroom at news.samsung.com.

About Street League Skateboarding
Since its inception in 2010, Street League Skateboarding (SLS) has propelled street skateboarding from a collection of independent standalone events to a renowned global series. As pioneers of street skateboarding’s premium qualification system and competition format, SLS offers an amateur-to-professional pathway and creates thrilling live events across the globe. The SLS Championship Tour is recognized as the world’s premier professional street skateboarding competition. Events take place on custom-built, one-of-a-kind, SLS-certified plazas in major cities around the world, with the best in the sport competing for the highest stakes. For more information, visit StreetLeague.com.

Samsung Galaxy S26 Ultra POV captures new perspectives at SLS DTLA Takeover on April 4, 2026 (Photo courtesy of Getty Images / Samsung).

Men’s top three finishers, including Jagger Eaton (L), take a Victory Selfie with the Samsung Galaxy S26 Ultra after competing at the SLS DTLA Takeover on April 4, 2026 (Photo courtesy of Getty Images / Samsung).

Photo – https://laotiantimes.com/wp-content/uploads/2026/04/samsung_galaxy_s26_ultra_pov_at_sls_dtla_takeover___2.jpg
Photo – https://laotiantimes.com/wp-content/uploads/2026/04/samsung_galaxy_s26_ultra_pov_at_sls_dtla_takeover___1.jpg
Photo – https://laotiantimes.com/wp-content/uploads/2026/04/skaters__including_jagger_eaton__take_a_victory_selfie_with_the_samsung_galaxy_s26_ultra_at_the_sls.jpg
Logo – https://laotiantimes.com/wp-content/uploads/2026/04/samsung_logo.jpg

NYSE issues a pre-market daily advisory direct from the trading floor.

NEW YORK, April 6, 2026 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

Kristen Scholer delivers the pre-market update on April 6th

• Equities rise Monday morning after a report indicates a push towards a ceasefire with Iran.
• The NYSE is partnering with leading AI conference HumanX at the Moscone Center in San Francisco this week and will have Ashley Mastronardi on the ground speaking to those transforming the space.
• James Foster, Chairman, President, and CEO of Charles River Laboratories (NYSE: CRL) will join NYSE Live to speak about his legacy of transformation.
• Three-time Olympic gold medalist Mikaela Shiffrin had an NYSE Bell moment on Thursday, ringing the Closing Bell to wrap up her most successful season yet.  

Opening Bell
Charles River Laboratories (NYSE: CRL) celebrates Jim Foster’s 50-year career

Closing Bell
Wichita State University commemorates its 100^th year.

For market insights, IPO activity, and today’s opening bell, download the NYSE TV App: TV.NYSE.com

Alpine skiing phenom Mikaela Shiffrin rang the NYSE bell.